BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 24922331)

  • 1. Bisphosphonate-induced osteonecrosis of the maxilla presenting as a cicatricial ectropion.
    Malik R; Fernando BS; Laitt RD; Leatherbarrow B
    Orbit; 2014 Oct; 33(5):369-71. PubMed ID: 24922331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bisphosphonates-induced osteonecrosis of the jaw: CT-findings].
    Maksimovic O; Denecke B; Pintoffl JP; Horger M
    Rofo; 2008 Apr; 180(4):277-9. PubMed ID: 18432565
    [No Abstract]   [Full Text] [Related]  

  • 3. Osteonecrosis of the jaws and bisphosphonate treatment in cancer patients.
    Wutzl A; Eisenmenger G; Hoffmann M; Czerny C; Moser D; Pietschmann P; Ewers R; Baumann A
    Wien Klin Wochenschr; 2006 Aug; 118(15-16):473-8. PubMed ID: 16957978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe spontaneous cases of bisphosphonate-related osteonecrosis of the jaws.
    Herbozo PJ; Briones DL; Ferres AJ; Torrealba RL
    J Oral Maxillofac Surg; 2007 Aug; 65(8):1650-4. PubMed ID: 17656297
    [No Abstract]   [Full Text] [Related]  

  • 5. Bisphosphonate-related osteonecrosis of the mandible and maxilla: clinical and imaging features.
    Gill SB; Valencia MP; Sabino ML; Heideman GM; Michel MA
    J Comput Assist Tomogr; 2009; 33(3):449-54. PubMed ID: 19478642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphosphonate-induced osteonecrosis of the jaw 32 months after interruption of zoledronate in a patient with multiple myeloma.
    Del Conte A; Bernardeschi P; La Ferla F; Turrisi G; D'Alessandro M; Montagnani F; Fiorentini G
    J Oral Maxillofac Surg; 2010 May; 68(5):1179-82. PubMed ID: 20185222
    [No Abstract]   [Full Text] [Related]  

  • 7. Consequence of therapy discontinuation in bisphosphonate-associated osteonecrosis of the jaws.
    Gallego L; Junquera L
    Br J Oral Maxillofac Surg; 2009 Jan; 47(1):67-8. PubMed ID: 18639371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of breast cancer with extensive osteonecrosis of maxilla induced by a bisphosphonate].
    Tanaka Y; Koga M; Yokomizo Y; Inokuchi S; Koga C; Kusukawa J
    Gan To Kagaku Ryoho; 2010 Apr; 37(4):681-5. PubMed ID: 20414026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteonecrosis of the maxilla in a patient with a history of bisphosphonate therapy.
    Melo MD; Obeid G
    J Can Dent Assoc; 2005 Feb; 71(2):111-3. PubMed ID: 15691429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisphosphonate-associated osteonecrosis of the jaws. Report of a case and literature review.
    Leite AF; Figueiredo PT; Melo NS; Acevedo AC; Cavalcanti MG; Paula LM; Paula AP; Guerra EN
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Jul; 102(1):14-21. PubMed ID: 16831667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent low-energy femoral shaft fractures and osteonecrosis of the jaw in a case of multiple myeloma treated with bisphosphonates.
    Grasko JM; Herrmann RP; Vasikaran SD
    J Oral Maxillofac Surg; 2009 Mar; 67(3):645-9. PubMed ID: 19231794
    [No Abstract]   [Full Text] [Related]  

  • 12. Bisphosphonate-associated osteonecrosis: a clinician's reference to patient management.
    Grewal VS; Fayans EP
    Todays FDA; 2008 Aug; 20(8):38-41, 43-6. PubMed ID: 18767452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisphosphonate-related osteonecrosis of the skull base.
    Khan AM; Sindwani R
    Laryngoscope; 2009 Mar; 119(3):449-52. PubMed ID: 19235747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endodontic implications of bisphosphonate-associated osteonecrosis of the jaws: a report of three cases.
    Katz H
    J Endod; 2005 Nov; 31(11):831-4. PubMed ID: 16249730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plain film and CBCT findings in a case of bisphosphonate-related osteonecrosis of the jaw.
    Singer SR; Mupparapu M
    Quintessence Int; 2009 Feb; 40(2):163-5. PubMed ID: 19169448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Maxillar osteonecrosis associated with bisphosphonate treatment and dental implants].
    Savoldelli C; Le Page F; Santini J; Scortecci G; Odin G
    Rev Stomatol Chir Maxillofac; 2007 Dec; 108(6):555-8. PubMed ID: 17631371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of osteonecrosis of the jaws and bisphosphonate pharmacotherapy: dental implications.
    Hay KD; Bishop PA
    N Z Dent J; 2006 Mar; 102(1):4-9. PubMed ID: 16568881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bisphosphonate-associated osteonecrosis. A clinician's reference to patient management.
    Grewal VS; Fayans EP
    N Y State Dent J; 2008 Jan; 74(1):38-44. PubMed ID: 18402375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bisphosphonate-induced osteonecrosis of the jaws.
    Throndson RR; Healy SM; Zwickey MR
    Tex Dent J; 2005 Sep; 122(9):960-5. PubMed ID: 16320503
    [No Abstract]   [Full Text] [Related]  

  • 20. Case of maxillary avascular necrosis due to oral bisphosphonates, presenting with signs of malignancy.
    Green R; Blackmore K; Robson A
    J Laryngol Otol; 2010 Dec; 124(12):1318-20. PubMed ID: 20441673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.